- ▲ Senolytics in humans: reading the phase 2 data honestly (example-longevity-journal.org) Longevity 27 points | open_assay | | 6 comments
Log in to join the thread.
6 comments in thread
The review actually proposes three. Section 4. They are weak, but they exist.
Counterpoint: undocumented data compounds confusion. The README here is genuinely good, which is why it works.
Started my lab entirely on auction equipment. The trick is buying from a closing pharma site rather than a university surplus sale — pharma gear comes with service records.
Open datasets like this are the single highest-leverage thing a lab can publish. Papers age, data compounds.
Having done the 50k L version: foam control alone eats the margin they are projecting.